Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRK-100STP Phase IIb/III Study in Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
KCT0000507Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beraprost in chronic kidney disease (CKD), sponsored by Astellas Pharma. Started Aug 2010; status: completed.
02
Drugs
beraprost
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on KCT0000507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000507.